Mustang Bio Inc (MBIO)
0.4741
+0.01
(+1.83%)
USD |
NASDAQ |
Jun 28, 16:00
0.4566
-0.02
(-3.69%)
After-Hours: 20:00
Mustang Bio Research and Development Expense (Annual): 41.04M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 41.04M |
| December 31, 2022 | 63.95M |
| December 31, 2021 | 55.71M |
| December 31, 2020 | 47.30M |
| Date | Value |
|---|---|
| December 31, 2019 | 36.32M |
| December 31, 2018 | 24.46M |
| December 31, 2017 | 20.38M |
| December 31, 2016 | 8.547M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
36.32M
Minimum
2019
63.95M
Maximum
2022
48.86M
Average
47.30M
Median
2020
Research and Development Expense (Annual) Benchmarks
| Fortress Biotech Inc | 106.07M |
| AIM ImmunoTech Inc | 10.94M |
| Perspective Therapeutics Inc | 21.31M |
| Protalix BioTherapeutics Inc | 17.09M |
| Armata Pharmaceuticals Inc | 33.77M |